Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N7VL
|
|||
Former ID |
DNC011291
|
|||
Drug Name |
Asp-BrPmp-Leu
|
|||
Synonyms |
Asp-BrPmp-Leu; CHEMBL1289231; BDBM50331945
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H29BrN3O9P
|
|||
Canonical SMILES |
CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)C(P(=O)(O)O)Br)NC(=O)C(CC(=O)O)N
|
|||
InChI |
1S/C20H29BrN3O9P/c1-10(2)7-15(20(29)30)24-19(28)14(23-18(27)13(22)9-16(25)26)8-11-3-5-12(6-4-11)17(21)34(31,32)33/h3-6,10,13-15,17H,7-9,22H2,1-2H3,(H,23,27)(H,24,28)(H,25,26)(H,29,30)(H2,31,32,33)/t13-,14-,15-,17?/m0/s1
|
|||
InChIKey |
VZSILTSENHCLNI-CKSGOKGCSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Leukocyte common antigen (PTPRC) | Target Info | Inhibitor | [1] |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
T cell receptor signaling pathway | ||||
Fc gamma R-mediated phagocytosis | ||||
Primary immunodeficiency | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Panther Pathway | B cell activation | |||
JAK/STAT signaling pathway | ||||
T cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | |||
TCR signaling in naï | ||||
TCR signaling in naï | ||||
CXCR4-mediated signaling events | ||||
Reactome | Phosphorylation of CD3 and TCR zeta chains | |||
Other semaphorin interactions | ||||
WikiPathways | Interferon type I signaling pathways | |||
EPO Receptor Signaling | ||||
B Cell Receptor Signaling Pathway | ||||
TCR signaling | ||||
Semaphorin interactions |
References | Top | |||
---|---|---|---|---|
REF 1 | A protected l-bromophosphonomethylphenylalanine amino acid derivative (BrPmp) for synthesis of irreversible protein tyrosine phosphatase inhibitors. Bioorg Med Chem. 2010 Dec 15;18(24):8679-86. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.